Scotland's national naloxone program: The prison experience.

Area of Science:

• Public Health
• Addiction Medicine
• Criminal Justice Health

Background:

• The Scottish national naloxone program, launched in 2011, aimed to reduce opioid-related deaths.
• Prisoners face a heightened risk of drug-related mortality post-liberation.
• Engaging this population is crucial for public health outcomes.

Purpose of the Study:

• To describe the adaptation and implementation of the national naloxone program within Scottish prisons.
• To highlight challenges and innovative solutions in prison-based harm reduction.
• To assess the program's impact on post-release mortality.

Main Methods:

• Programmatic review and commentary on implementation strategies.
• Analysis of operational and individual barriers encountered.
• Description of innovations and partnership working to overcome challenges.

Main Results:

• Overcoming implementation barriers through innovation and collaboration.
• Establishment of a largely consistent prison-based naloxone program model.
• Observed reduction in opioid-related mortality among prisoners on release.

Conclusions:

• The Scottish prison naloxone program has successfully adapted to implementation challenges.
• Partnership and innovation have been key to program sustainability.
• The program effectively reduces opioid-related deaths in a high-risk population.